Key result
Pulsed field ablation cuts AF recurrence ~32% and reduces overall complications versus cryoablation.
Why the study?
The study aimed to provide a comprehensive comparison of pulsed field ablation and cryoablation for treating atrial fibrillation regarding efficacy, procedural characteristics, and safety profiles.
Does pulsed field ablation reduce AF recurrence and complications compared to cryoablation in patients with atrial fibrillation?
Meta-Analysis (n=4,638)
Does pulsed field ablation reduce AF recurrence and complications compared to cryoablation in patients with atrial fibrillation?
In a meta-analysis of 20 studies, pulsed field ablation demonstrated superior efficacy and lower overall complications compared to cryoablation for atrial fibrillation, despite higher rates of cardiac tamponade and atrial tachycardia.
Answers are grounded in this paper and cite their sources.
May favor PFA over cryoablation for AF; hypothesis-generating pending randomized confirmation.
Background: Atrial fibrillation (AF) remains the most common sustained cardiac arrhythmia. Pulsed field ablation (PFA) and cryoablation (CA) aim to isolate pulmonary veins and prevent AF recurrence. This meta-analysis aims to provide a comprehensive comparison of PFA and CA in treatment of AF in context of efficacy, procedural characteristics, and safety profiles. Methods: A comprehensive literature search of databases (PubMed, Cochrane Library, Science Direct and Google Scholar) was conducted from their inception to September 2024. Statistical analyses were conducted using Cochrane’s RevMan 5.4 software. Results: Twenty studies (n = 4638; PFA = 2172, CA = 3033) were included in this meta-analysis. Regarding efficacy outcomes, PFA significantly reduced AF recurrence (odds ratio [OR] = 0.68 [0.50–0.94], P = .02) and improved 1-year freedom from atrial arrhythmia (OR = 1.65 [1.18–2.31], P = .004) compared to CA. Procedurally, it demonstrated shorter procedure duration (mean difference [MD] = −11.07 [−14.57 to −7.56], P < .00001), lower contrast dye use (MD = −51.62 [−66.35 to −36.88], P < .00001), and smaller fluoroscopy dose (MD = −5.28 [−9.32 to −1.24], P = .01), though it required more applications (MD = 20.73 [4.98–36.48], P = .01), longer fluoroscopy time (MD = 1.55 [0.68–2.42], P = .0005), and higher post-pulmonary vein isolation high sensitivity cardiac troponin T levels (MD = 570.40 [410.94–729.86], P < .00001). Regarding safety, PFA was associated with a lower overall complication rate (OR = 0.46 [0.32–0.66], P < .0001) and reduced risk of persistent (OR = 0.13 [0.04–0.42], P = .0008) and transient (OR = 0.12 [0.05–0.30], P < .00001) phrenic nerve palsy, but a higher incidence of cardiac tamponade (OR = 2.86 [1.26–6.48], P = .01) and atrial tachycardia (OR = 2.62 [1.41–4.87], P = .002). It also showed superior postoperative heart rate improvement (MD = −8.76 [−15.12 to −2.40], P = .007). Conclusion: PFA offers superior efficacy and some procedural advantages over CA in AF treatment, though with increased risk of certain complications.
No takes yet. Share an insight, caveat, or question.
Bokhari et al. (2026) conducted a meta-analysis in Atrial fibrillation (n=4,638). Pulsed field ablation vs. Cryoablation was evaluated on Atrial fibrillation recurrence (OR 0.68, 95% CI 0.50-0.94, p=.02). Pulsed field ablation reduced atrial fibrillation recurrence compared to cryoablation and lowered overall complication rates.
Synapse has enriched 10 related papers. Consider them for comparative context: